Autoimmune hepatitis (AIH) patients experience increased mortality and severe side effects from non-specific immunosuppressive therapy, highlighting an urgent need for targeted treatment approaches. Here, we aimed to delineate the cellular and molecular network underlying AIH within its spatial context and to validate a key therapeutic target in a clinical trial.
Journal of Hepatology published a clinical update in Research Highlights on 19 Mar 2026.
The item focuses on Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis.
Review the original article for the full source wording and details.